Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201310141 Principal Investigator: Adkins, Douglas
Title: A Double-Blind, Randomized, Placebo-Controlled, Dose-Escalating, Multicenter Study of SGX942 for the Attenuation of Oral Mucositis in Patients Being Treated with Concomitant Chemoradiation (CRT) for the Treatment of Squamous Cell Carcinoma of the Head and Neck
Phase: II Disease Site: Lip, Oral Cavity and Pharynx
Participating Site(s):
 
Main Campus
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to find out what effects, good and /or bad, of a drug called SGX942 compared to placebo has on you and any resulting oral mucositis you may develop as a result of chemoradiation therapy.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)